quinazolines has been researched along with Hyperuricemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Choudhary, MI; Gul, A; Khan, KM; Saad, SM; Zafar, H | 1 |
Dong, YZ; Li, F; Lin, ZJ; Zhang, B; Zhang, D; Zhang, XM | 1 |
Bao, W; Cheng, SB; Chin, YE; Liu, N; Qiu, A; Shi, Y; Wang, L; Xiong, C; Xu, L; Yan, H; Yang, T; Zhuang, S | 1 |
3 other study(ies) available for quinazolines and Hyperuricemia
Article | Year |
---|---|
Topics: Enzyme Inhibitors; Humans; Hyperuricemia; Molecular Docking Simulation; Quinazolines; Structure-Activity Relationship; Xanthine Oxidase | 2023 |
Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments.
Topics: Alanine Transaminase; Alkaline Phosphatase; Antimetabolites; Aspartate Aminotransferases; Benzylisoquinolines; Cell Line; Chemical and Drug Induced Liver Injury; Computational Biology; Drugs, Chinese Herbal; Flavonoids; Gene Expression Regulation; Gout Suppressants; Hepatocytes; Humans; Hyperuricemia; Indole Alkaloids; L-Lactate Dehydrogenase; Liver; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Protein Binding; Quinazolines; Saponins; Uric Acid | 2019 |
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.
Topics: Animals; Chemokines; Cytokines; Disease Progression; ErbB Receptors; Fibroblasts; Fibrosis; Gefitinib; Hyperuricemia; Inflammation; Kidney; Kidney Diseases; Male; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Risk Factors; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Uric Acid | 2015 |